Key result
CMR establishes a new diagnosis in ~42% of athletes with suspected structural heart disease.
Why the study?
The study evaluated the diagnostic utility of CMR in athletes with suspected SHD and investigated whether the athlete's heart phenotype indicates a healthy heart less prone to developing SHD.
Does cardiac magnetic resonance (CMR) imaging improve diagnostic yield in athletes with suspected structural heart disease?
Observational (n=154)
No
Does cardiac magnetic resonance (CMR) imaging improve diagnostic yield in athletes with suspected structural heart disease?
CMR is a highly useful imaging modality that establishes a definitive diagnosis in over 40% of athletes suspected of having structural heart disease, demonstrating that pathology can exist concurrently with physiological athlete's heart adaptation.
Answers are grounded in this paper and cite their sources.
Supports CMR for clarifying suspected SHD in athletes; leaves open its effect on outcomes independent of athlete's heart phenotype.
Cardiac magnetic resonance (CMR) is a second-line imaging test in cardiology. Balanced enlargement of heart chambers called athlete’s heart (AH) is a part of physiological adaptation to regular physical activity. The aim of this study was to evaluate the diagnostic utility of CMR in athletes with suspected structural heart disease (SHD) and to analyse the relation between the coexistence of AH and SHD. We wanted to assess whether the presence of AH phenotype could be considered as a sign of a healthy heart less prone to development of SHD. This retrospective, single centre study included 154 consecutive athletes (57 non-amateur, all sports categories, 87% male, mean age 34 ± 12 years) referred for CMR because of suspected SHD. The suspicion was based on existing guidelines including electrocardiographic and/or echocardiographic changes suggestive of abnormality but without a formal diagnosis. CMR permitted establishment of a new diagnosis in 66 patients (42%). The main diagnoses included myocardial fibrosis typical for prior myocarditis (n = 21), hypertrophic cardiomyopathy (n = 17, including 6 apical forms), other cardiomyopathies (n = 10) and prior myocardial infarction (n = 6). Athlete’s heart was diagnosed in 59 athletes (38%). The presence of pathologic late gadolinium enhancement (LGE) was found in 41 patients (27%) and was not higher in athletes without AH (32% vs. 19%, p = 0.08). Junction-point LGE was more prevalent in patients with AH phenotype (22% vs. 9%, p = 0.02). Patients without AH were not more likely to be diagnosed with SHD than those with AH (49% vs. 32%, p = 0.05). Based on the results of CMR and other tests, three patients (2%) were referred for ICD implantation for the primary prevention of sudden cardiac death with one patient experiencing adequate intervention during follow-up. The inclusion of CMR into the diagnostic process leads to a new diagnosis in many athletes with suspicion of SHD and equivocal routine tests. Athletes with AH pattern are equally likely to be diagnosed with SHD in comparison to those without AH phenotype. This shows that the development of AH and SHD can occur in parallel, which makes differential diagnosis in this group of patients more challenging.
No takes yet. Share an insight, caveat, or question.
Małek et al. (2022) conducted an observational in Suspected structural heart disease in athletes (n=154). Cardiac magnetic resonance (CMR) imaging was evaluated on Establishment of a new diagnosis of structural heart disease. Cardiac magnetic resonance established a new diagnosis in 42% of athletes with suspected structural heart disease, with diagnoses equally likely in those with and without the athlete's heart phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: